Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Kidney Transplant Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

3 recruiting trials for Kidney Transplant. Eligibility criteria explained in plain English.

TrialFinderData lists 3 Kidney Transplant clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Every phased trial in this set is Phase 3 (1 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.

Research is led by Vertex Pharmaceuticals Incorporated (1), University of Edinburgh (1), IRCCS Azienda Ospedaliero-Universitaria di Bologna (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is Biological/Vaccine (biological, 1 trial), followed by MRI, Blood tests.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
3
Total Trials
3
Recruiting Now
1
Phase 3 Trials
3
Sponsors

Track Kidney Transplant trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGPhase 3NCT06832410

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

This study will evaluate the efficacy, safety, and tolerability of VX-880 in participants with Type 1 Diabetes (TID) with a kidney transplant.

Sponsor: Vertex Pharmaceuticals IncorporatedEnrolling: 107 locations
RECRUITINGNCT06698614

MEMRI and Kidney Disease

Acute kidney injury (AKI) is common and costly.1 Although patients who suffer an episode of AKI may recover, many will go on to develop cardiovascular disease and chronic kidney...

Sponsor: University of EdinburghEnrolling: 1201 location
RECRUITINGNCT06794203

Hyperthyroidism as a Potential Predictive of Worse Outcome of Renal Graft

The objectives of the study are: to research the association, if any, between the occurrence of thyroid function changes in the immediate post-transplant period and the prognosis...

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di BolognaEnrolling: 1001 location

Frequently Asked Questions

There are currently 3 clinical trials for Kidney Transplant, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Kidney Transplant, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 1 Phase 3 trials for Kidney Transplant, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.